OXFORD, Ohio and COCONUT CREEK, Fla., April 26, 2021 /CNW/ — PsyBio Therapeutics Corp. (TSXV: PSYB) (“PsyBio” or the “Company“), a biotechnology company pioneering the next generation of targeted psychoactive medications, announces today that it has amended its master sponsored agreement with Miami University based in Oxford, Ohio (the “Amended Agreement“) to extend and expand the research efforts…


Previous articleCybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003
Next articleMindMed Begins Trading on Nasdaq